Skip Nav Destination
Pentostatin, Cyclophosphamide, and Rituximab Followed by Alemtuzumab for Relapsed or Refractory Chronic Lymphocytic Leukemia: A Phase 2 Trial of the ECOG-Acrin Cancer Research Group (E2903)
Acta Haematol (2019) 142 (4): 224–232.
This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.
- Neha R. Raghani
- Mehul R. Chorawala
- Mayuresh Mahadik
- Rakesh B. Patel
- Bhupendra G. Prajapati
- Priyajeet S. Parekh
Medical Oncology (2024) 41 (2)
- Cho-Hao Lee
- Yi-Ying Wu
- Tzu-Chuan Huang
- Chin Lin
- Yi-Fen Zou
- Ju-Chun Cheng
- Po-Huang Chen
- Hong-Jie Jhou
- Ching-Liang Ho
Cochrane Database of Systematic Reviews (2024) 2024 (1)
- Barbara Kutryb-Zając
- Ada Kawecka
- Khrystyna Nasadiuk
- Alicja Braczko
- Klaudia Stawarska
- Elisabetta Caiazzo
- Patrycja Koszałka
- Carla Cicala
Biomedicine & Pharmacotherapy (2023) 165: 115184.
- Hongyu Zhang
- Ran Liu
- Tingting Lou
- Pei Zhao
- Suying Wang
Fermentation (2022) 8 (9): 459.
- Hayder M. Al-kuraishy
- Ali I. Al-Gareeb
- Engy Elekhnawy
- Gaber El-Saber Batiha
Egyptian Journal of Medical Human Genetics (2022) 23 (1)
- Minmin ZHAO
- Hongyu ZHANG
- Tingting LOU
- Kongxiang ZHAO
- Suying WANG
Chinese Journal of Chromatography (2021) 39 (7): 744.